Exalys Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Latest Deal Type
  • Out of Business

Exalys General Information

Description

Developer of novel anti-inflammatory therapeutics designed for the treatment of inflammatory disorders including pain and renal dysfunction. The company is focused on the development of first-in-class therapies for the treatment of inflammatory disorders with an initial target indication of the prevention of postoperative delirium, providing patients with an effective treatment for serious and potentially life-threatening conditions which have limited treatment options.

Contact Information

Formerly Known As
Derexa Therapeutics
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 44 Tehama Street
  • San Francisco, CA 94105
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 44 Tehama Street
  • San Francisco, CA 94105
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Exalys Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business 07-Nov-2022 Completed Out of Business
1. Early Stage VC (Series A) 16-Jul-2020 Completed Generating Revenue
To view Exalys’s complete valuation and funding history, request access »

Exalys Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Exalys’s complete cap table history, request access »

Exalys Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of novel anti-inflammatory therapeutics designed for the treatment of inflammatory disorders including pain an
Drug Discovery
San Francisco, CA

Montreal, Canada
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Exalys Competitors (1)

One of Exalys’s competitors is Laurent Pharma, a Venture Capital-Backed company based in Montreal, Canada.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Laurent Pharma Venture Capital-Backed Montreal, Canada
You’re viewing 1 of 1 competitors. Get the full list »

Exalys FAQs

  • When was Exalys founded?

    Exalys was founded in 2018.

  • Where is Exalys headquartered?

    Exalys is headquartered in San Francisco, CA.

  • What industry is Exalys in?

    Exalys’s primary industry is Drug Discovery.

  • Is Exalys a private or public company?

    Exalys is a Private company.

  • What is Exalys’s current revenue?

    The current revenue for Exalys is .

  • How much funding has Exalys raised over time?

    Exalys has raised $15M.

  • Who are Exalys’s competitors?

    Laurent Pharma is a competitor of Exalys.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »